May 29, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Biologics coordinators exert much control over the medications used in rheumatology clinics, with 80% reporting “significant” influence over biosimilar brand selection, according to findings from a recent survey by Spherix Global Insights.“The fact that biologic coordinators report having significant influence over biosimilar brand selection highlights how central these roles
May 29, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

ORLANDO — Initiation of biologic treatment for asthma is low despite availability, and adherence is low as well despite its…

Prescriptions for an adalimumab biosimilar among new users rose from 0% to 24% after CVS Caremark added it to its formulary, but…

For decades, biologics have been the gold standard for psoriasis treatment. Now, the psoriasis therapeutic landscape is…

ORLANDO — Patients with asthma who used biologics during pregnancy had less risk for complications than those who did not,…

As biologics have come to supersede small molecules in the biopharma industry’s pipeline, the mounting complexity behind the…

The novel interleukin-17AA targeted molecule izokibep showed ACR50 response rates of more than 50% in psoriatic arthritis at 52…